Next Article in Journal
Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance
Previous Article in Journal
Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex
Previous Article in Special Issue
Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle
Article Menu

Export Article

Open AccessArticle
Cancers 2014, 6(1), 179-192; doi:10.3390/cancers6010179

A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer

1
Urology Service, Basurto University Hospital, Bilbao 48013, Bizkaia, Spain
2
Basque Foundation for Health Innovation and Research (BIOEF), DNA Laboratory, Basurto Hospital, Bilbao 48013, Bizkaia, Spain
3
Genome Analysis Platform, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio 48160, Bizkaia, Spain
4
Metabolomics Unit, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio 48160, Bizkaia, Spain
5
IKERBASQUE, Basque Foundation for Science, Bilbao 48011, Bizkaia, Spain
*
Author to whom correspondence should be addressed.
Received: 21 October 2013 / Revised: 20 December 2013 / Accepted: 13 January 2014 / Published: 22 January 2014
(This article belongs to the Special Issue Exosomes in Cancer Development)
View Full-Text   |   Download PDF [570 KB, uploaded 22 January 2014]   |  

Abstract

Bladder cancer is one of the most common cancers and, together with prostate carcinoma, accounts for the majority of the malignancies of the genitourinary tract. Since prognosis ameliorates with early detection, it will be beneficial to have a repertoire of diagnostic markers that could complement the current diagnosis protocols. Recently, cell-secreted extracellular vesicles have received great interest as a source of low invasive disease biomarkers because they are found in many body fluids, including urine. The current work describes a pilot study to generate an array-based catalogue of mRNA associated to urinary vesicles, and also a comparison with samples obtained from bladder cancer patients. After an analysis of presence/absence of transcripts in bladder cancer EVs, a list of genes was selected for further validation using PCR technique. We found four genes differentially expressed in cancer samples. LASS2 and GALNT1 were present in cancer patients, while ARHGEF39 and FOXO3 were found only in non-cancer urinary vesicles. Previous studies have pointed to the involvement of those genes in tumour progression and metastasis. View Full-Text
Keywords: extracellular vesicles; bladder cancer; gene expression analysis; LASS2; GALNT1; ARHGEF39; FOXO3 extracellular vesicles; bladder cancer; gene expression analysis; LASS2; GALNT1; ARHGEF39; FOXO3
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Perez, A.; Loizaga, A.; Arceo, R.; Lacasa, I.; Rabade, A.; Zorroza, K.; Mosen-Ansorena, D.; Gonzalez, E.; Aransay, A.M.; Falcon-Perez, J.M.; Unda-Urzaiz, M.; Royo, F. A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer. Cancers 2014, 6, 179-192.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top